缺乏动物咬伤病例的文档及其对狂犬病生物制剂利用的影响
Rohit Batish1, Simmi Oberoi1, Virender Verma2
1Department of Community Medicine, GMC, Patiala, Punjab, India.
Journal of family medicine and primary care
|July 1, 2024
概括
在印度,缺乏以前动物咬伤治疗的文件,导致不必要的再接种疫苗. 这导致狂犬病疫苗的大量浪费,这是一个重要的资源,可以用于更多需要帮助的患者.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 狂犬病在全球和印度造成了重大健康和经济负担.
- 印度面临着抗狂犬病疫苗的短缺,由于先前治疗方法的文件不足而加剧.
- 每年都有数以百万计的狗咬伤,很少有百分比的人得到了及时的暴露后预防 (PEP).
研究的目的:
- 调查印度先前的动物咬伤治疗缺乏文件的反狂犬病疫苗浪费的程度.
- 量化再接种对疫苗资源的影响.
主要方法:
- 进行了一项为期2年的回顾性,横截面研究 (2021年6月至2023年6月).
- 分析了来自4291名参加动物咬伤诊所的患者的数据.
- 专注于再暴露病例和以前治疗的记录.
主要成果:
- 大多数患者在24小时内出现了第3类,无缘无故的咬伤,通常在下肢.
- 在217例再暴露病例中,185例 (85.25%) 缺乏之前治疗的记录.
- 这种缺乏记录需要全面的再接种疫苗课程,导致生物浪费.
结论:
- 很大一部分的狂犬病疫苗被浪费,原因是以前动物咬伤治疗的文档不足.
- 实施强大的文档系统可以防止疫苗浪费,优化资源配置.
- 解决这个问题对于改善印度狂犬病预防和控制至关重要.
更多相关视频
07:40Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
Published on: June 29, 2020
13.4K
10:26Author Spotlight: A Cost-Effective Genomic Workflow for Advancing Rabies Control in Resource-Limited Settings
Published on: August 18, 2023
5.1K
相关概念视频
Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
564
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
564
Bioequivalence studies: Biowaivers
410
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
410
Drug Products: Biologics, Biosimilars and Interchangeables
357
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
357
